Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Jan 19, 2025; 15(1): 98737
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.98737
Published online Jan 19, 2025. doi: 10.5498/wjp.v15.i1.98737
Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression
Juan Liu, Yan-Mei Lu, Bei-Lin Wang, Department of Urology Surgery, Zhumadian Central Hospital, Zhumadian 463000, Henan Province, China
Yan-Ping Guo, Department of Psychiatry, Zhumadian Mental Hospital, Zhumadian 463000, Henan Province, China
Author contributions: Liu J and Guo YP conceived this study, Lu YM collected and organized clinical data, and Wang BL conducted statistical analysis.
Institutional review board statement: The study was reviewed and approved by the Institutional Review Board of Zhumadian Central Hospital.
Informed consent statement: The Institutional Review Board approved an exemption from informed consent.
Conflict-of-interest statement: The authors declare no conflict of interest.
Data sharing statement: The data used in this study can be obtained from the corresponding author upon request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Juan Liu, MBBS, Nurse, Department of Urology Surgery, Zhumadian Central Hospital, No. 747 Zhonghua Road, Zhumadian 463000, Henan Province, China.
Received: September 12, 2024
Revised: October 10, 2024
Accepted: October 18, 2024
Published online: January 19, 2025
Processing time: 97 Days and 0.4 Hours
Revised: October 10, 2024
Accepted: October 18, 2024
Published online: January 19, 2025
Processing time: 97 Days and 0.4 Hours
Core Tip
Core Tip: Urinary system tumors often cause varying degrees of negative psychological symptoms, such as depression and dysphoria. These psychological factors significantly impact patients’ immune function and indirectly affect the intervention and prognosis of patients with cancer. Epirubicin (EPI) can improve the prognosis of patients with urinary system tumors, but it also has certain side effects. Mindfulness interventions are beneficial for enhancing psychological adaptability in cancer patients. In this study, the combination of EPI and mindfulness intervention achieved remarkable clinical results in patients with depression-complicated urinary system tumors.